Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...
Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.
Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...
Tamoxifen treatment for premenopausal women with breast cancer is independently associated with an increased risk of endometrial cancer and other uterine diseases, according to findings from a large ...
Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the ...
Figure 3. (A) Adenomyosis with glands (Thick arrow) in the myometrium (thin arrow). (5x, H and E stain); (B) Endometrial hyperplasia with surface lining on the right (Thick arrows), the gland to ...
A sequential doublet chemotherapy regimen in patients (pts) with advanced endometrial adenocarcinoma (EC) and gynecological mixed müllerian tumors (MMT). Maintaining activity with tolerability? No ...
Bayer, a global leader in women’s healthcare, announced the clinical phase III study SUNFLOWER (Study ofUnderstandingNAEH - treatmenteFficacy ofLevonOrgestrel – IUS inWomenElectingnon-suRgical options ...
Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...
Endometrial cancer is one of the few cancers that doesn’t stay quiet. That’s why you should never brush off spotting between periods or any bleeding after menopause. When caught early, this cancer is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results